$PFHO
PACIFIC HEALTH CARE ORGANIZATION INC

2024 Q2 Form 10-K Financial Statement

#000118518524000392 Filed on April 16, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023
Revenue $1.570M $1.642M $5.630M
YoY Change 20.87% 12.25% -2.0%
Cost Of Revenue $334.7K $384.5K $1.213M
YoY Change 25.17% 1.96% 9.44%
Gross Profit $1.235M $1.258M $4.417M
YoY Change 19.75% 15.82% -4.74%
Gross Profit Margin 78.68% 76.59% 78.45%
Selling, General & Admin $1.034M $944.0K $3.701M
YoY Change 17.91% -15.05% -5.99%
% of Gross Profit 83.72% 75.05% 83.79%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.114K $7.530K $37.53K
YoY Change -2.39% -30.6% 10.38%
% of Gross Profit 0.74% 0.6% 0.85%
Operating Expenses $1.378M $953.9K $4.951M
YoY Change 19.43% -14.99% -2.51%
Operating Profit $192.0K $304.0K $678.5K
YoY Change 32.3% -943.6% 1.86%
Interest Expense $107.0K $108.0K $410.0K
YoY Change 6.83% 296.91% 1407.17%
% of Operating Profit 55.73% 35.52% 60.42%
Other Income/Expense, Net $55.77K $201.7K
YoY Change 81.36% 10.56%
Pretax Income $299.0K $411.9K $1.088M
YoY Change 21.9% -4759.73% 57.0%
Income Tax $83.44K $130.6K $320.6K
% Of Pretax Income 27.91% 31.71% 29.45%
Net Earnings $215.6K $281.3K $767.9K
YoY Change 22.18% -2409.28% 55.8%
Net Earnings / Revenue 13.73% 17.13% 13.64%
Basic Earnings Per Share $0.02 $0.06
Diluted Earnings Per Share $0.02 $0.02 $0.06
COMMON SHARES
Basic Shares Outstanding 12.80M shares 12.80M shares 12.80M shares
Diluted Shares Outstanding 12.82M shares 12.82M shares

Balance Sheet

Concept 2024 Q2 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.70M $10.44M $10.44M
YoY Change 7.42% -3.16% -3.16%
Cash & Equivalents $2.619M $2.566M
Short-Term Investments $8.084M $7.878M $7.878M
Other Short-Term Assets $226.2K $218.6K $218.6K
YoY Change -6.09% 24.64% 24.64%
Inventory
Prepaid Expenses $179.7K
Receivables $941.3K $1.053M $1.021M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $11.87M $11.68M $11.68M
YoY Change 7.23% -1.81% -1.81%
LONG-TERM ASSETS
Property, Plant & Equipment $64.63K $77.39K $133.9K
YoY Change -19.37% -20.54% -9.26%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.110K $7.110K $7.110K
YoY Change 0.0% 7.69% 7.73%
Total Long-Term Assets $71.74K $141.0K $141.0K
YoY Change -17.79% -8.53% -8.54%
TOTAL ASSETS
Total Short-Term Assets $11.87M $11.68M $11.68M
Total Long-Term Assets $71.74K $141.0K $141.0K
Total Assets $11.94M $11.82M $11.82M
YoY Change 7.03% -1.9% -1.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $163.1K $159.8K $168.6K
YoY Change 103.24% -39.25% -38.8%
Accrued Expenses $424.3K $367.6K $373.6K
YoY Change 23.26% 10.54% 4.93%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $726.0K $1.008M $1.008M
YoY Change -9.16% 42.24% 42.24%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $11.97K $11.97K
YoY Change 13.78% 13.78%
Total Long-Term Liabilities $0.00 $11.97K $11.97K
YoY Change 13.78% 13.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $726.0K $1.008M $1.008M
Total Long-Term Liabilities $0.00 $11.97K $11.97K
Total Liabilities $726.0K $1.020M $1.020M
YoY Change -10.91% 38.8% 38.8%
SHAREHOLDERS EQUITY
Retained Earnings $10.79M $10.37M
YoY Change 8.81% -4.72%
Common Stock $12.80K $12.80K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.22M $10.80M $10.80M
YoY Change
Total Liabilities & Shareholders Equity $11.94M $11.82M $11.82M
YoY Change 7.03% -1.9% -1.9%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $215.6K $281.3K $767.9K
YoY Change 22.18% -2409.28% 55.8%
Depreciation, Depletion And Amortization $9.114K $7.530K $37.53K
YoY Change -2.39% -30.6% 10.38%
Cash From Operating Activities -$41.39K $502.4K $932.4K
YoY Change -113.43% 261.59% 31.09%
INVESTING ACTIVITIES
Capital Expenditures $2.030K $17.52K $17.52K
YoY Change 61.11% -17.55% -54.93%
Acquisitions
YoY Change
Other Investing Activities -$176.2K -$285.7K $824.3K
YoY Change -115.94% -96.72% -109.45%
Cash From Investing Activities -$178.2K -$293.2K $806.8K
YoY Change -116.14% -96.65% -109.21%
FINANCING ACTIVITIES
Cash Dividend Paid $1.210M
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 410.0 -$1.210M
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -41.39K 502.4K $932.4K
Cash From Investing Activities -178.2K -293.2K $806.8K
Cash From Financing Activities 0.000 410.0 -$1.210M
Net Change In Cash -219.6K 209.6K $529.6K
YoY Change -172.87% -102.44% -106.58%
FREE CASH FLOW
Cash From Operating Activities -$41.39K $502.4K $932.4K
Capital Expenditures $2.030K $17.52K $17.52K
Free Cash Flow -$43.42K $484.8K $914.8K
YoY Change -114.15% 312.0% 36.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-50009
CY2023 dei Entity Registrant Name
EntityRegistrantName
PACIFIC HEALTH CARE ORGANIZATION, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
UT
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0285238
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
19800 MacArthur Boulevard, Suites 306 & 307
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92612
CY2023 dei City Area Code
CityAreaCode
949
CY2023 dei Local Phone Number
LocalPhoneNumber
721-8272
CY2023 dei No Trading Symbol Flag
NoTradingSymbolFlag
true
CY2023 dei Security12g Title
Security12gTitle
$.001 par value, common voting shares
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
4146510 usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12800000 shares
CY2023 dei Auditor Name
AuditorName
GreenGrowth CPAs
CY2023 dei Auditor Location
AuditorLocation
Los Angeles, California
CY2023 dei Auditor Firm
AuditorFirmId
6580
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2565992 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2036432 usd
CY2023Q4 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
7877752 usd
CY2022Q4 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
8748435 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1053394 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
942797 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
32814 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7807 usd
CY2023Q4 us-gaap Deferred Income Taxes And Other Assets Current
DeferredIncomeTaxesAndOtherAssetsCurrent
38871 usd
CY2022Q4 us-gaap Deferred Income Taxes And Other Assets Current
DeferredIncomeTaxesAndOtherAssetsCurrent
0 usd
CY2023Q4 us-gaap Other Receivables
OtherReceivables
0 usd
CY2022Q4 us-gaap Other Receivables
OtherReceivables
3000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
179702 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
276828 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
200009 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
179423 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
175355 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
11682897 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
11898212 usd
CY2023Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
255783 usd
CY2022Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
256500 usd
CY2023Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
21620 usd
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
20328 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
277403 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
77394 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
97405 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
56489 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
50137 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7110 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6602 usd
CY2023Q4 us-gaap Assets
Assets
11823890 usd
CY2022Q4 us-gaap Assets
Assets
12052356 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
159789 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
263022 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
367609 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
332551 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
296452 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3132 usd
CY2023Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
109013 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
37000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
44519 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
39620 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
30919 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
33544 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1008301 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
708869 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11970 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10517 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15679 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1020271 usd
CY2022Q4 us-gaap Liabilities
Liabilities
735065 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
16000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
16000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
16 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
16 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
12800 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
12800 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
416057 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
416057 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10374746 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10888418 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
10803619 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
11317291 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11823890 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12052356 usd
CY2023 us-gaap Revenues
Revenues
5629918 usd
CY2022 us-gaap Revenues
Revenues
5744957 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
37527 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33998 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
25941 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-626 usd
CY2023 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
225780 usd
CY2022 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
227406 usd
CY2023 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2565199 usd
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2689842 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
330236 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
314013 usd
CY2023 us-gaap General Insurance Expense
GeneralInsuranceExpense
311779 usd
CY2022 us-gaap General Insurance Expense
GeneralInsuranceExpense
315919 usd
CY2023 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
699770 usd
CY2022 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
610277 usd
CY2023 us-gaap Other Expenses
OtherExpenses
201696 usd
CY2022 us-gaap Other Expenses
OtherExpenses
182437 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
553455 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
705567 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
4951383 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
5078833 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
678535 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
666124 usd
CY2023 us-gaap Interest Income Other
InterestIncomeOther
409950 usd
CY2022 us-gaap Interest Income Other
InterestIncomeOther
27199 usd
CY2023 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
409950 usd
CY2022 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
27199 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1088485 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
693323 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
320557 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200437 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
767928 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
492886 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10824405 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
492886 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
11317291 usd
CY2023 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1280000 usd
CY2023 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1600 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
767928 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
10803619 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
767928 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
492886 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
37527 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33998 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
25941 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-626 usd
CY2023 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
31363 usd
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
27125 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
111531 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6374 usd
CY2023 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
0 usd
CY2022 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-19779 usd
CY2023 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-38871 usd
CY2022 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0 usd
CY2023 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
0 usd
CY2022 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-10055 usd
CY2023 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-3000 usd
CY2022 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 usd
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
508 usd
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-20186 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
4347 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
78378 usd
CY2023 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-15679 usd
CY2022 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
8525 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-103233 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
218123 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
35058 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
17056 usd
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
293320 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
3132 usd
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2625 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
932359 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
711237 usd
CY2023 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
16312707 usd
CY2022 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
0 usd
CY2023 us-gaap Payments To Acquire Restricted Certificates Of Deposit
PaymentsToAcquireRestrictedCertificatesOfDeposit
15488403 usd
CY2022 us-gaap Payments To Acquire Restricted Certificates Of Deposit
PaymentsToAcquireRestrictedCertificatesOfDeposit
8721310 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17516 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
38867 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
806788 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8760177 usd
CY2023 us-gaap Payments Of Dividends
PaymentsOfDividends
1209587 usd
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
0 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1209587 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
529560 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-8048940 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2036432 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10085372 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2565992 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2036432 usd
CY2023 us-gaap Interest Paid
InterestPaid
0 usd
CY2022 us-gaap Interest Paid
InterestPaid
0 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
82000 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
170000 usd
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
56489 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
52563 usd
CY2022Q4 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
8721310 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
202693 usd
CY2022Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2023-06-08
CY2023Q2 us-gaap Dividends Cash
DividendsCash
1281600 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.1
CY2023Q2 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
7846389 usd
CY2023Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
203019 usd
CY2023Q2 us-gaap Investment Maturity Date
InvestmentMaturityDate
2023-12-08
CY2023Q4 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
7846389 usd
CY2023Q4 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-06-08
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
405712 usd
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 usd
CY2023 us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
31363 usd
CY2022 us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
27125 usd
CY2023Q4 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">E. <span style="text-decoration:underline">Concentrations of Credit Risk</span></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Financial instruments that potentially subject the Company to concentrations of credit risks consist of cash and cash equivalents. The Company places its cash and cash equivalents at well-known, quality financial institutions. At times, such cash and investments may be in excess of the FDIC insurance limit. As noted above, in December 2023, the Company purchased $7,846,389 of U.S. Treasury bills, which will mature on June 8, 2024. As of December 31, 2023, the Company held $2,565,992 in cash, which we believe is enough to cover operating expenses until the bills mature and limits our exposure of holding such cash in a bank in excess of the FDIC insurance limit.</p>
CY2023 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
7846389 usd
CY2023Q4 us-gaap Cash
Cash
2565992 usd
CY2023 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
16000 shares
CY2023 us-gaap Net Income Loss
NetIncomeLoss
767928 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
492886 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12800000 shares
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2023 us-gaap Net Income Loss
NetIncomeLoss
767928 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
492886 usd
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12816000 shares
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">H. <span style="text-decoration:underline">Use of Estimates</span></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in these audited consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Significant estimates include the values assigned to the allowance for doubtful accounts and accruals for income taxes.</p>
CY2020Q1 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
four-shares-for-one-share
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023 us-gaap Preferred Stock Voting Rights
PreferredStockVotingRights
20,000
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
16000 shares
CY2023 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1
CY2023 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
1281600 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12800000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12800000 shares
CY2023Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
109013 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
37000 usd
CY2023Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
0 usd
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
0 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
32814 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7807 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
56489 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
56489 usd
CY2023Q4 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
277403 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
276828 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
200009 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
179423 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
37527 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33998 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
259943 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
127240 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
115164 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
64672 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-40946 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
6400 usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-13604 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
2125 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
320557 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200437 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
20794 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
27247 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
9181 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
2184 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
15805 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
14024 usd
CY2023Q4 pfho Deferred Tax Assets Tax Deferred Expense Lease Obligation
DeferredTaxAssetsTaxDeferredExpenseLeaseObligation
15805 usd
CY2022Q4 pfho Deferred Tax Assets Tax Deferred Expense Lease Obligation
DeferredTaxAssetsTaxDeferredExpenseLeaseObligation
14024 usd
CY2023Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
8652 usd
CY2022Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
9384 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
41832 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
0 usd
CY2023Q4 pfho Net Deferred Tax Asset
NetDeferredTaxAsset
38871 usd
CY2022Q4 pfho Net Deferred Tax Asset
NetDeferredTaxAsset
-15679 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
225646 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
138683 usd
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
77375 usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
46045 usd
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
10326 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
12070 usd
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
7210 usd
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
3639 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
320557 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200437 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 usd
CY2023 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
The years 2020, 2021, 2022, and 2023 are still open for examination.
CY2015Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P79M
CY2015Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
9439 sqft
CY2022Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12M
CY2023Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12M
CY2022Q2 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
320 sqft
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
59217 usd
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
41898 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y3M
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0575 pure
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
56489 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
50137 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
44519 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
39620 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11970 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10517 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
56489 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
50137 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
47079 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
12138 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
59217 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2728 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
56489 usd
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
41898 usd
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
105292 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
100053 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
99943 usd
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
185763 usd
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
151150 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
26984 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
22960 usd
CY2023Q4 pfho Accrued Accounting Fees Current
AccruedAccountingFeesCurrent
16325 usd
CY2022Q4 pfho Accrued Accounting Fees Current
AccruedAccountingFeesCurrent
42426 usd
CY2023Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
8800 usd
CY2022Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
12472 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
29684 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3600 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
367609 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
332551 usd
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
8000000 shares
CY2023 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001138476

Files In Submission

Name View Source Status
0001185185-24-000392-index-headers.html Edgar Link pending
0001185185-24-000392-index.html Edgar Link pending
0001185185-24-000392.txt Edgar Link pending
0001185185-24-000392-xbrl.zip Edgar Link pending
ex_652640.htm Edgar Link pending
ex_652641.htm Edgar Link pending
ex_652642.htm Edgar Link pending
ex_652643.htm Edgar Link pending
ex_652828.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
logo1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
pacifichco20231231_10k.htm Edgar Link pending
pacifichco20231231_10kimg001.jpg Edgar Link pending
pfho-20231231.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
pfho-20231231_cal.xml Edgar Link unprocessable
pfho-20231231_def.xml Edgar Link unprocessable
pfho-20231231_lab.xml Edgar Link unprocessable
pfho-20231231_pre.xml Edgar Link unprocessable
pacifichco20231231_10k_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable